8158 — China Regenerative Medicine International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
HK$91.28m
Enterprise Value
HK$134.41m
Revenue
HK$72.06m

Annual balance sheet for China Regenerative Medicine International, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	9.93	1.85	3.33	22.7	8.17
Net Total Accounts Receivable
Net Total Receivables	197	238	158	28.6	5.09
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	258	249	169	58.3	86
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.753	26.8	17.3	6.99	23.1
Long Term Notes Receivable
Other Long Term Assets
Total Assets	259	276	186	136	168
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	147	158	148	58.9	75.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	147	172	174	111	115
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	112	104	11.8	25.2	53.5
Total Liabilities & Shareholders' Equity	259	276	186	136	168
Total Common Shares Outstanding